Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd has announced a new substantial holder, with a total voting power disclosed across various classes of ordinary securities. The substantial holder and associates, including State Street Bank and Trust Company and its subsidiaries, have acquired relevant interests in the company through different mechanisms, such as collateral securities and lent securities, as well as through investment management and trusteeship. The exact details of their voting rights and the consideration paid for these interests have been outlined, but specifics such as forward-looking statements have been omitted from this summary.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.